Time to screen
Who should be screened for type 1 diabetes, how should it be done and who should be carrying it out? Professors Chant...
Fasting safely
How to prepare diabetes patients who want to fast for Ramadan, how new technologies have affected risk stratification...
Triglycerides, cardiovascular risk and omega-3 fatty acids
Professor Philippe Gabriel Steg and Dr Handrean Soran discuss the REDUCE-IT trial outcomes in detail, compare it with...
Psychosocial aspects of diabetes technology
Professors Bill Polonsky and Frank Snoek explore the benefits and drawbacks of new technologies for people with diabe...
Diabetes distress and depression
Diabetes distress is malleable to intervention in clinical care and needs to be clearly distinguished from depression...
Complications in type 2 diabetes
Covering non-alcoholic fatty liver disease, chronic kidney disease and retinopathy, Dr Ana Cebrián and Profess...
HHS: past, present and future
Despite carrying several-fold greater risk of mortality than DKA, hyperosmolar hyperglycaemic syndrome (HHS) is under...
A triangle of care: why the liver should not be forgotten
One in three or four patients with type 2 diabetes has NASH and one in 10 has cirrhosis, so diabetologists should mak...
Cognitive function and hypoglycaemia
Professors Stephanie Amiel and Rory McCrimmon join forces to examine what we know about hypoglycaemia’s acute a...
Do novel diabetes technologies really lighten the load?
New diabetes technologies have come a long way but we need more automation to relieve the burden on people with diabe...
Managing type 1 diabetes in adults: draft recommendations
The ADA/EASD draft consensus report on managing type 1 diabetes in adults is now available. Professors Pratik Choudha...
Reducing cardiovascular risk in diabetes
New treatments could make a big difference in our ongoing struggle against cardiovascular risk in diabetes. But are w...
The women who never should be missed
Better to get a false positive than to miss a woman with gestational diabetes, say Professor Fidelma Dunne (National ...
You are now entering the metabolic domain
What’s in the pipeline for cardiometabolic medicine? Professors Naveed Sattar (University of Glasgow, UK) and D...
This sporting life
These days sport for people with type 1 diabetes can be about winning, not just taking part. Professors Miles Fisher ...
What’s next for metabolic surgery?
Medicines for weight loss are grabbing the headlines but there’s still an important role for surgery in treatin...
New tools for the job
Continuing our series in which two experts discuss the long and short of an aspect of diabetes treatment or research,...
Heart savers
Launching our new series in which two experts discuss the long and the short of an aspect of diabetes treatment or re...